| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Japanese Encephalitis Vaccines | 100 | + | |
2 | Viral Vaccines | 35 | + | |
3 | Antibodies, Viral | 23 | + | |
4 | Diphtheria Antitoxin | 23 | + | |
5 | Diphtheria-Tetanus Vaccine | 21 | + | |
6 | Acyclovir | 17 | + | |
7 | Vaccines, Inactivated | 14 | + | |
8 | Viral Envelope Proteins | 12 | + | |
9 | Potassium Channels, Voltage-Gated | 12 | + | |
10 | Vaccines, Attenuated | 9 | + | |
11 | West Nile Virus Vaccines | 8 | + | |
12 | Antibodies, Neutralizing | 7 | + | |
13 | Vidarabine | 7 | + | |
14 | Immunoglobulin G | 6 | + | |
15 | Autoantibodies | 6 | + | |
16 | Sulfadiazine | 6 | + | |
17 | Hu Paraneoplastic Encephalomyelitis Antigens | 6 | + | |
18 | Immunoglobulins, Intravenous | 5 | + | |
19 | Vaccines, Synthetic | 5 | + | |
20 | Viral Proteins | 5 | + | |
21 | Glutamate Decarboxylase | 5 | + | |
22 | Viral Fusion Proteins | 5 | + | |
23 | Vaccines | 4 | + | |
24 | Isatin | 4 | + | |
25 | Tilorone | 4 | + | |
26 | Immunoglobulin M | 4 | + | |
27 | Viral Structural Proteins | 4 | + | |
28 | Oxytetracycline | 4 | + | |
29 | DNA, Viral | 4 | + | |
30 | Tetracyclines | 4 | + | |
31 | Vaccines, DNA | 4 | + | |
32 | Purine Nucleosides | 3 | + | |
33 | Receptors, N-Methyl-D-Aspartate | 3 | + | |
34 | Poly U | 3 | + | |
35 | Bacterial Vaccines | 3 | + | |
36 | Doxycycline | 3 | + | |
37 | Arabinose | 3 | + | |
38 | Deoxyribonuclease HindIII | 3 | + | |
39 | Pyrimethamine | 3 | + | |
40 | Atovaquone | 3 | + | |
41 | Antibodies, Bacterial | 3 | + | |
42 | Dengue Vaccines | 3 | + | |
43 | Viral Nonstructural Proteins | 2 | + | |
44 | Methylprednisolone | 2 | + | |
45 | Poly G | 2 | + | |
46 | Antibodies | 2 | + | |
47 | Naphthoquinones | 2 | + | |
48 | Cobra Cardiotoxin Proteins | 2 | + | |
49 | Inosine Nucleotides | 2 | + | |
50 | Trimethoprim-Sulfamethoxazole Combination | 2 | + | |
51 | Membrane Glycoproteins | 2 | + | |
52 | Idoxuridine | 2 | + | |
53 | Fenitrothion | 2 | + | |
54 | Ganciclovir | 2 | + | |
55 | Immune Sera | 2 | + | |
56 | Poly I-C | 2 | + | |
57 | Thiosemicarbazones | 2 | + | |
58 | Glycoproteins | 2 | + | |
59 | Staphylococcal Protein A | 2 | + | |
60 | Pentamidine | 2 | + | |
61 | Nucleic Acids | 2 | + | |
62 | Nerve Tissue Proteins | 2 | + | |
63 | gamma-Globulins | 2 | + | |
64 | Chemokines, CX3C | 2 | + | |
65 | Methisazone | 2 | + | |
66 | Bromodeoxyuridine | 2 | + | |
67 | Cytokines | 2 | + | |
68 | Gold Colloid | 2 | + | |
69 | Foscarnet | 2 | + | |
70 | Phosphonoacetic Acid | 2 | + | |
71 | Measles Vaccine | 2 | + | |
72 | Butylated Hydroxyanisole | 2 | + | |
73 | Recombinant Fusion Proteins | 1 | + | |
74 | Transferrin-Binding Protein B | 1 | + | |
75 | Inulin | 1 | + | |
76 | Receptors, Lysophospholipid | 1 | + | |
77 | Clindamycin | 1 | + | |
78 | Steroids | 1 | + | |
79 | Minocycline | 1 | + | |
80 | Viral Matrix Proteins | 1 | + | |
81 | Peptides | 1 | + | |
82 | Oligonucleotides | 1 | + | |
83 | Receptors, GABA-B | 1 | + | |
84 | Antibodies, Monoclonal, Murine-Derived | 1 | + | |
85 | Cytarabine | 1 | + | |
86 | Antibodies, Monoclonal | 1 | + | |
87 | Ribonucleosides | 1 | + | |
88 | Interferon Type I | 1 | + | |
89 | Rabies Vaccines | 1 | + | |
90 | Nucleocapsid Proteins | 1 | + | |
91 | Antibodies, Protozoan | 1 | + | |
92 | Interferon-gamma | 1 | + | |
93 | Recombinant Proteins | 1 | + | |
94 | Immunoglobulins | 1 | + | |
95 | Amantadine | 1 | + | |
96 | Organophosphorus Compounds | 1 | + | |
97 | Dapsone | 1 | + | |
98 | Gene Products, pol | 1 | + | |
99 | Aerosols | 1 | + | |
100 | Zidovudine | 1 | + | |
101 | Glucocorticoids | 1 | + | |
102 | RNA, Viral | 1 | + | |
103 | HIV Core Protein p24 | 1 | + | |
104 | Adrenal Cortex Hormones | 1 | + | |
105 | Prednisolone | 1 | + | |
106 | Fluorodeoxyglucose F18 | 1 | + | |
107 | Nitric Oxide Synthase | 1 | + | |
108 | Dexamethasone | 1 | + | |
109 | Nitric Oxide Synthase Type II | 1 | + | |